ORGANOGENESIS HOLDINGS INC. Net Income (Loss) Attributable to Noncontrolling Interest
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Net Income (Loss) Attributable to Noncontrolling Interest of $863.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-09.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2020-03-09
- ORGANOGENESIS HOLDINGS INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2017-06-30 was $273.00K.
- ORGANOGENESIS HOLDINGS INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2017-03-31 was $590.00K.
- ORGANOGENESIS HOLDINGS INC. net income (loss) attributable to noncontrolling interest for fiscal 2017 was $863.00K, a 61.14% decline from fiscal 2016.
- ORGANOGENESIS HOLDINGS INC. net income (loss) attributable to noncontrolling interest for fiscal 2016 was $2.22M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|
| 2017-12-31 | $863.00K 10-K · filed 2020-03-09 | ||
| 2017-06-30 | $273.00K 10-K · filed 2019-03-18 | $863.00K derived: sum of 2 quarters · filed 2019-03-18 | |
| 2017-03-31 | $590.00K 10-K · filed 2019-03-18 | ||
| 2016-12-31 | $2.22M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |